{"id":"https://openalex.org/W2584576127","doi":"https://doi.org/10.1182/blood.v118.21.2920.2920","title":"Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells","display_name":"Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2584576127","doi":"https://doi.org/10.1182/blood.v118.21.2920.2920","mag":"2584576127"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.2920.2920","doi":"https://doi.org/10.1182/blood.v118.21.2920.2920","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.2920.2920","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018088896","display_name":"Michele Cea","orcid":"https://orcid.org/0000-0002-1530-6729","observed_orcids":["https://orcid.org/0000-0002-1530-6729"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Michele Cea","raw_affiliation_strings":["Internal Medicine, University of Genoa, Genoa, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, University of Genoa, Genoa, Italy,","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062694802","display_name":"Antonia Cagnetta","orcid":"https://orcid.org/0000-0003-1973-3768","observed_orcids":["https://orcid.org/0000-0003-1973-3768"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Antonia Cagnetta","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019802024","display_name":"Yu\u2010Tzu Tai","orcid":"https://orcid.org/0000-0001-6199-3569","observed_orcids":["https://orcid.org/0000-0001-6199-3569"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu-Tzu Tai","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006765393","display_name":"Dharminder Chauhan","orcid":"https://orcid.org/0000-0002-5548-6138","observed_orcids":["https://orcid.org/0000-0002-5548-6138"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dharminder Chauhan","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090141367","display_name":"Sun\u2010Young Kong","orcid":"https://orcid.org/0000-0003-0620-4058","observed_orcids":["https://orcid.org/0000-0003-0620-4058"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sun-Young Kong","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002203533","display_name":"Teresa Calimeri","orcid":"https://orcid.org/0000-0003-0833-4761","observed_orcids":["https://orcid.org/0000-0003-0833-4761"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Teresa Calimeri","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065898212","display_name":"Jana Jakub\u0131\u0301kov\u00e1","orcid":"https://orcid.org/0000-0003-2593-569X","observed_orcids":["https://orcid.org/0000-0003-2593-569X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jana Jakubikova","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006211032","display_name":"Alessio Nencioni","orcid":"https://orcid.org/0000-0001-5068-8884","observed_orcids":["https://orcid.org/0000-0001-5068-8884"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessio Nencioni","raw_affiliation_strings":["Internal Medicine, University of Genoa, Genoa, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, University of Genoa, Genoa, Italy,","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078922292","display_name":"Marco Gobbi","orcid":"https://orcid.org/0000-0003-0756-109X","observed_orcids":["https://orcid.org/0000-0003-0756-109X"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Marco Gobbi","raw_affiliation_strings":["Internal Medicine, University of Genoa, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, University of Genoa, Genova, Italy","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060112940","display_name":"Franco Patrone","orcid":"https://orcid.org/0000-0003-4170-9131","observed_orcids":["https://orcid.org/0000-0003-4170-9131"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Franco Patrone","raw_affiliation_strings":["Internal Medicine, University of Genoa, Genoa, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, University of Genoa, Genoa, Italy,","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5002203533","https://openalex.org/A5006211032","https://openalex.org/A5018088896","https://openalex.org/A5034020009","https://openalex.org/A5060112940","https://openalex.org/A5062468245","https://openalex.org/A5062694802","https://openalex.org/A5065898212","https://openalex.org/A5078922292"],"corresponding_institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I83816512"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.37565032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"118","issue":"21","first_page":"2920","last_page":"2920"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.249099999666214,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.08749999850988388,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/nad-salvage-pathway","display_name":"NAD+ salvage pathway","score":0.9559999704360962},{"id":"https://openalex.org/keywords/visfatin","display_name":"visfatin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/nampt-inhibitors","display_name":"NAMPT inhibitors","score":0.7599999904632568},{"id":"https://openalex.org/keywords/fk866","display_name":"FK866","score":0.996999979019165},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5669999718666077},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7580000162124634},{"id":"https://openalex.org/keywords/nad-metabolism","display_name":"NAD+ metabolism","score":0.5299999713897705},{"id":"https://openalex.org/keywords/metabolic-reprogramming","display_name":"metabolic reprogramming","score":0.48100000619888306},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5289999842643738},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.3610000014305115},{"id":"https://openalex.org/keywords/lc3","display_name":"LC3","score":0.3959999978542328},{"id":"https://openalex.org/keywords/myeloma-cell-lines","display_name":"myeloma cell lines","score":0.6159999966621399},{"id":"https://openalex.org/keywords/patient-derived-cells","display_name":"patient-derived cells","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2780391879","wikidata":"https://www.wikidata.org/wiki/Q18035058","display_name":"Nicotinamide phosphoribosyltransferase","level":4,"score":0.8948782682418823},{"id":"https://openalex.org/C75520062","wikidata":"https://www.wikidata.org/wiki/Q15321392","display_name":"NAD+ kinase","level":3,"score":0.8230077028274536},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.5555393099784851},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5484330654144287},{"id":"https://openalex.org/C2776901170","wikidata":"https://www.wikidata.org/wiki/Q12499775","display_name":"Nicotinamide adenine dinucleotide","level":4,"score":0.4823448061943054},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46025076508522034},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4468454420566559},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.44265297055244446},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.43090328574180603},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.39716091752052307},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3243488669395447},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.233035147190094},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2323569357395172},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1968468427658081},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1778683066368103},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v118.21.2920.2920","doi":"https://doi.org/10.1182/blood.v118.21.2920.2920","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.2920.2920","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:iris.unige.it:11567/386231","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11567/386231","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2006170651","https://openalex.org/W2315089601","https://openalex.org/W7030060184","https://openalex.org/W4405273437","https://openalex.org/W2026164253","https://openalex.org/W2320389026","https://openalex.org/W2086634689","https://openalex.org/W1964212045","https://openalex.org/W2983560773","https://openalex.org/W7017360240"],"abstract_inverted_index":{"Abstract":[0,1],"2920":[2],"Background:":[3],"Nicotinamide":[4,47],"adenine":[5],"dinucleotide":[6],"(NAD+)":[7],"is":[8,50,65,274],"a":[9,235,262,307,456,521],"coenzyme":[10],"crucially":[11],"involved":[12],"in":[13,54,136,180,241,257,268,277,306,323,349,396,401,449,455,459,465,526,551],"several":[14],"cellular":[15],"functions,":[16],"including":[17],"energy":[18],"metabolism,":[19],"reactive":[20],"oxygen":[21],"species":[22],"scavenging,":[23],"DNA":[24],"repair,":[25],"and":[26,43,76,79,87,91,121,164,168,198,212,220,225,309,353,374,432,468,480,505,531],"gene":[27],"expression.":[28],"Intracellular":[29,229],"NAD+":[30,56,230,366],"stores":[31],"are":[32,111],"continuously":[33],"replenished":[34],"through":[35],"pathways":[36,430],"whose":[37],"activity":[38,143,395,541],"depends":[39],"on":[40,124,559,570,581,592,605,616,627],"the":[41,51,55,181,203,213,253,297,344,358,402,412,417,466],"tissue":[42],"availability":[44],"of":[45,156,185,187,215,255,265,333,347,360,379,388,399,427,441,445,471,484,489,524,536,563,574,585,596,609,620,631],"substrates.":[46],"phosphoribosyltransferase":[48],"(Nampt)":[49],"rate-limiting":[52],"enzyme":[53,267,289],"salvage":[57],"pathway":[58],"from":[59,317],"nicotinamide.":[60],"During":[61],"neoplastic":[62],"transformation,":[63],"Nampt":[64,100,131,142,256,273,298,380,525,540],"upregulated":[66],"to":[67,95,99,166,410,437,474,538,547],"compensate":[68],"for":[69,108,149],"increased":[70,122,482],"metabolic":[71,119],"demands.":[72],"It":[73],"promotes":[74],"myeloid":[75],"lymphoid":[77],"differentiation":[78],"increases":[80],"specific":[81],"cytokine":[82],"production":[83],"(TNF-":[84],"\u03b1,":[85],"IL-6":[86],"VEGF).":[88],"Importantly,":[89,327],"cancer":[90,138],"leukaemia":[92],"cells":[93,177,207,285,292],"appear":[94],"be":[96],"more":[97],"sensitive":[98,163],"inhibitor":[101,299],"drugs":[102],"than":[103],"normal":[104,291,334],"cells.":[105,326,338,355,515],"The":[106,183,534],"reasons":[107],"this":[109,266,288,294],"selectivity":[110],"not":[112,330],"fully":[113],"understood,":[114],"but":[115],"may":[116],"include":[117],"aberrant":[118],"demands":[120],"reliance":[123],"NAD+-dependent":[125],"enzymes.":[126],"Promising":[127],"results":[128,320],"obtained":[129],"with":[130,199,210,313,369,496],"inhibitors":[132],"(such":[133],"as":[134,172,174],"FK866)":[135],"preclinical":[137],"models":[139,398],"suggest":[140],"that":[141,364],"represents":[144],"an":[145,314,560,571,582,593,606,617,628],"innovative":[146],"therapeutic":[147],"target":[148],"novel":[150,169],"anticancer":[151],"agents.":[152],"Methods:":[153],"A":[154],"panel":[155],"eighteen":[157,269],"different":[158],"MM":[159,176,258,270,284,302,325,350,389,400,429,514,527],"cell":[160,271,279,303,351,390,491,528],"lines,":[161],"both":[162],"resistant":[165],"conventional":[167],"anti-myeloma":[170],"drugs,":[171],"well":[173],"patient":[175,283,324,354,549],"were":[178,208,321],"used":[179],"study.":[182],"mechanism":[184],"action":[186],"FK866":[188,211,300,328,348,370,392,420,452,476,495,537],"was":[189,218,232,239,447],"investigated":[190],"by":[191,222,381,416,462],"Annexin-V/propidium":[192],"iodide":[193],"staining,":[194],"thymidine":[195,340],"incorporation,":[196],"Western-blotting,":[197],"lentivirus-mediated":[200],"shRNAs.":[201],"For":[202],"autophagy":[204],"assay,":[205],"EGFP-LC3+":[206],"treated":[209],"number":[214],"GFP-LC3":[216],"punctae":[217],"analyzed":[219],"quantified":[221],"fluorescence":[223],"microscopy":[224],"flow":[226],"cytometry,":[227],"respectivley.":[228],"content":[231],"measured":[233,240],"using":[234,243],"biochemical":[236],"assay.":[237,249],"Angiogenesis":[238],"vitro":[242],"Matrigel":[244],"capillary-like":[245],"tube":[246],"structure":[247],"formation":[248,483],"Results:":[250],"To":[251,356],"study":[252],"role":[254,523],"cells,":[259],"we":[260,362],"performed":[261],"protein":[263],"analysis":[264],"lines.":[272],"constitutively":[275],"activated":[276],"all":[278],"lines":[280,352],"tested.":[281],"Moreover,":[282],"highly":[286],"express":[287],"whereas":[290],"lack":[293],"protein.":[295],"Indeed,":[296],"decreased":[301,368],"line":[304],"viability":[305,332],"dose":[308],"time":[310],"dependent":[311],"manner,":[312],"IC50":[315],"ranging":[316],"3\u201330nM.":[318],"Similar":[319],"observed":[322,448],"did":[329],"inhibit":[331,539],"peripheral":[335],"blood":[336],"mononuclear":[337],"Tritiated":[339],"uptake":[341],"assay":[342],"confirmed":[343],"antiproliferative":[345],"effects":[346],"examine":[357],"mechansim":[359],"action,":[361,442],"showed":[363],"intracellular":[365],"levels":[367],"treatment":[371,421,453],"at":[372],"24":[373],"48":[375],"hours.":[376],"Furthermore,":[377],"knock-down":[378],"small":[382],"interfering":[383],"RNAs":[384],"caused":[385],"significant":[386],"inhibition":[387],"growth.":[391],"triggered":[393,481],"anti-MM":[394],"our":[397],"bone":[403],"marrow":[404],"(BM)":[405],"microenvironment,":[406],"confirming":[407,487],"its":[408,439,544],"ability":[409,535],"overcome":[411],"proliferative":[413],"advantage":[414],"conferred":[415],"BM":[418],"milieu.":[419],"also":[422],"inhibited":[423,477],"angiogenesis":[424],"via":[425],"suppression":[426],"pivotal":[428,522],"PI3K/AKT":[431],"ERK.":[433],"In":[434],"further":[435],"studies":[436],"delineate":[438],"mechanisms":[440],"no":[443],"activation":[444],"apoptosis":[446],"treated-cells.":[450],"Instead":[451],"resulted":[454],"marked":[457],"increase":[458],"autophagy,":[460],"evidenced":[461],"autophagic":[463,490],"vacuoles":[464],"cytoplasm":[467],"proteolitic":[469],"processing":[470],"endogenous":[472],"LC3-I":[473],"LC3-II.":[475],"mTOR":[478],"signaling":[479],"EGFP-LC3":[485],"punctae,":[486],"involvement":[488],"death.":[492],"Finally,":[493],"combined":[494],"bortezomib":[497],"(CI":[498,502,507],"<":[499,503,508],"0.6),":[500],"melphalan":[501],"0.9),":[504],"dexamethasone":[506],"0.8),":[509],"induced":[510],"synergistic":[511],"cytotoxicity":[512],"against":[513],"Conclusion:":[516],"Our":[517],"data":[518],"therefore":[519],"show":[520],"growth,":[529],"survival":[530],"drug":[532],"resistance.":[533],"strongly":[542],"supports":[543],"clinical":[545],"evaluation":[546],"improve":[548],"outcome":[550],"MM.":[552],"Disclosures:":[553],"Hideshima:":[554],"Acetylon:":[555,625],"Consultancy.":[556],"Anderson:Celgene:":[557],"Membership":[558,569,580,591,604,615,626],"entity's":[561,572,583,594,607,618,629],"Board":[562,573,584,595,608,619,630],"Directors":[564,575,586,597,610,621,632],"or":[565,576,587,598,611,622,633],"advisory":[566,577,588,599,612,623,634],"committees;":[567,578,589,600,613,624],"Millennium:":[568],"Onyx:":[579],"Merck:":[590],"Bristol":[601],"Myers":[602],"Squibb:":[603],"Novartis:":[614],"committees.":[635]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-02-10T00:00:00"}